NDC product
irinotecan hydrochloride
NDC 0703-4437 · Teva Parenteral Medicines, Inc
Key facts
| Product NDC | 0703-4437 |
|---|---|
| Proprietary name | irinotecan hydrochloride |
| Labeler | Teva Parenteral Medicines, Inc |
| Marketing category | ANDA |
| Application number | ANDA090101 |
| Marketing start | Nov 26, 2008 |
| Marketing end | Oct 15, 2011 |
| Listing certified through | Oct 15, 2011 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: